UPDATED: Medtronic denies involvement with on-demand orgasm implant

Medtronic signs on to test orgasm device

Medical device industry giant Medtronic (NYSE:MDT) told MassDevice.com today that despite reports of the company’s participation in upcoming studies, Medtronic is not involved with research on an implantable neurostimulator designed for treatment of sexual dysfunction.

Reports have circulated today that Medtronic has signed on to conduct research with physician and inventor Dr. T. Stuart Meloy, who holds a patent on technology that uses traditional nerve stimulation to target nerves in the spine and produce orgasms at the push of a remote-controlled button.

North Carolina surgeon Dr. Stuart Meloy developed the system after unintentionally triggering an intense response in a female patient undergoing surgery to implant a neurostimulator for an unrelated condition, he’s said. The experience encouraged him to explore the potential for an orgasm-spurring system and he has been working on the technology for more nearly 15 years now, having landed a patent in 2001.

Clinical trials are slated to begin later this year, according to New Scientist, which reported that Meloy expects to work with Medtronic. Another report from SeekingAlpha.com stated that “Medtronic has signed on to conduct tests." Numerous other reports have also tied Medtronic to future testing of the technology.

"Medtronic is not involved in any research regarding sexual dysfunction, and we have no device intended for this indication," Medtronic Neuromodulation spokesman Justin Ihle told MassDevice.com today.

When asked directly if the above reports were inaccurate, Ihle responded simply that "Medtronic is not involved in this research."

Meloy could not be reached for comment. Advanced Interventional Pain Management, for which Meloy serves as president, was closed today due to inclement weather. Other attempts to reach Meloy were also unsuccessful.

Meloy has said in patent documents that his is the 1st technology to recognize the potential for implanted nerve stimulation to produce orgasms, although it does happen on accident from time to time. Meloy described a situation in which a patient’s spinal cord stimulator, intended for relief of hip pain, became dislodged over time and caused patient to "experience genital stimulation rather than pain relief."

"The patient vocalized intense genital stimulation without discomfort," patent documents report. Meloy has been chasing that outcome, testing areas of the spine for sexual stimulation and conducting small trials.

Meloy in 2006 published data from a small clinical trial, implanting 11 women with neurostimulators and targeting sexual stimulation. Ten of the 11 women reported improvement in sexual health, describing "greater frequency in sexual activity, increased lubrication, and overall satisfaction," according to the findings. Once the implants were removed all women returned to their previous "anorgasmic" status.

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply